Partnerships are a critical aspect of NuMedii’s business. We expect to advance several of NuMedii’s de-risked drug candidates via collaborations and partners.
NuMedii is actively seeking partners for the clinical development and commercialization of its de-risked drug candidates. If you are a pharmaceutical company that would like access to pipeline products with a high likelihood of success in your disease area of interest, please contact us at email@example.com.
NuMedii can also discover new uses for drug candidates that have been discontinued or de-prioritized. If you are a pharmaceutical company that would like to leverage your past development investments to efficiently expand your proprietary pipeline, please contact us at